申请人:Ajinomoto Co., Inc.
公开号:US05229400A1
公开(公告)日:1993-07-20
A piperidine derivative of general formula (I) or a pharmaceutically acceptable salt thereof: ##STR1## wherein ##STR2## is any of several specified aromatic-containing groups; X is selected from one of several hetero atom-containing groups or C.sub.2 alkylene or a cyano-containing group; and Q is phenyl, cyclohexyl, piperidinyl, tetrahydropyranyl, pyridyl, pyrrolyl, N-methylpyrrolyl, thienyl, furyl, 1-hexyl, or cyano; from 1 to 3 hydrogen atoms in Q may be independently substituted by alkyl of from 1 to 3 carbon atoms, perfluoroalkyl of from 1 to 3 carbon atoms, acylamino of from 1 to 6 carbon atoms, perfluoroacylamino of from 1 to 3 carbon atoms, alkoxy of from 1 to 3 carbon atoms, alkanesulfonylamino of from 1 to 3 carbon atoms, perfluoroalkanesulfonylamino of from 1 to 3 carbon atoms, acetoxy of from 1 to 3 carbon atoms, aminocarbonyl, aminosulfonyl, fluoro, chloro, cyano, hydroxy, nitro, amino, imidazolylmethyl, cinnamoylamino, p-fluorobenzoyl, cyanomethyl, cyanoethyl, methoxyacetoxy, alkoxycarbonyl of from 1 to 3 carbon atoms; 1 is an integer of from 0 to 1; m is an integer of from 0 to 1; n is an integer of from 0 to 6. The derivatives are useful as antiarrhythmic agents.
通用公式(I)的哌啶衍生物或其药用盐:其中##STR2##是指几种特定的含芳香基团之一;X从几种含杂原子基团或C.sub.2烷基烯或含氰基团中选择;Q为苯基、环己基、哌啶基、四氢吡喃基、吡啶基、吡咯基、N-甲基吡咯基、噻吩基、呋喃基、1-己基或氰基;Q中的1至3个氢原子可独立地被1至3个碳原子的烷基、1至3个碳原子的全氟烷基、1至6个碳原子的酰胺基、1至3个碳原子的全氟酰胺基、1至3个碳原子的烷氧基、1至3个碳原子的烷磺酰胺基、1至3个碳原子的全氟烷磺酰胺基、1至3个碳原子的乙酰氧基、氨基甲酰基、氨基磺酰基、氟、氯、氰、羟基、硝基、氨基、咪唑甲基、肉桂酰胺基、对-氟苯甲酰基、氰甲基、氰乙基、甲氧基乙酰氧基、1至3个碳原子的烷氧羰基;1为0至1的整数;m为0至1的整数;n为0至6的整数。这些衍生物可用作抗心律失常药物。